文献速递胃肠动力与功能性疾病消化内镜

常见良性肛门直肠疾病循证实践综述:痔、肛裂、排便障碍与大便失禁

An Evidence-Based Practical Review on Common Benign Anorectal Disorders: Hemorrhoids, Anal Fissure, Dyssynergic Defecation, and Fecal Incontinence.
PubMed 文献 · Gastroenterology · 2025-11-14

本综述聚焦痔、慢性肛裂、排便障碍(DD)和大便失禁(FI)的临床特征、检查与治疗。强调对轻度患者首选生活方式、饮食调整和/或药物治疗;治疗按阶梯进行,痔可行橡胶圈结扎,肛裂用局部钙通道拮抗剂或硝酸甘油,DD和FI可用生物反馈治疗。

要点

  • 痔轻度患者首选保守治疗,I-II度可行橡胶圈结扎,更严重者考虑切除术。
  • 慢性肛裂先用局部钙通道拮抗剂或硝酸甘油,无效可考虑肉毒毒素或侧方内括约肌切开术。
  • 排便障碍和大便失禁均可采用生物反馈治疗,并结合针对症状的肠道调节剂。

核心结论

  • 多数轻度良性肛门直肠疾病患者可通过生活方式、饮食调整和/或药物治疗获得改善。
  • 治疗应阶梯进行,从保守治疗开始,手术保留给更严重疾病,并需平衡长期疗效与风险。

研究设计与样本

  • 本文为循证实践综述,聚焦痔、慢性肛裂、排便障碍和大便失禁的临床特征、检查与治疗。

主要发现

  • 肛裂和排便障碍与便秘密切相关,而大便失禁通常与腹泻相关。
  • 生物反馈治疗对排便障碍有效,并可联合肠道调节剂用于大便失禁。
  • 大便失禁的微创选项包括骶神经调节和肛门葡聚糖omer注射,结肠造口或肛门括约肌成形术现已较少需要。

关键数值与推荐

  • I-II度痔可行橡胶圈结扎;更严重疾病通常需切除术。
  • 慢性肛裂局部治疗使用钙通道拮抗剂或硝酸甘油,后续可考虑肉毒毒素,侧方内括约肌切开术较少用。

临床怎么用

  • 对疑似良性肛门直肠疾病患者,应通过问卷评估肠道症状,并通过直肠指检评估肛门无力和/或排便障碍。
  • 治疗按阶梯选择:轻度患者先保守治疗,必要时行肛门直肠功能检查排除严重疾病和结构异常。

局限性

  • 生物反馈治疗可及性不广泛,许多患者由盆底物理治疗师治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This evidence-based practical review is focused on the clinical features, investigations, and treatment of hemorrhoids, chronic anal fissures, dyssynergic defecation (DD), and fecal incontinence (FI), which are arguably the most common benign anorectal diseases encountered by gastroenterologists. These diseases are associated with bowel disturbances, which should be evaluated preferably with questionnaires, and with anal weakness and/or DD, often evident on a thorough digital rectal examination. Fissures and DD are closely linked to constipation, whereas FI is typically associated with diarrhea. For most patients with mild symptoms, lifestyle changes, dietary adjustments, and/or pharmacotherapy suffice. Some patients require tests to rule out serious diseases; assess anorectal functions, which are discussed in detail; and to identify structural abnormalities, such as rectoceles, which are occasionally clinically significant. Treatments are applied stepwise, starting with conservative therapy with simpler treatments when feasible (eg, rubber band ligation for grade I-II hemorrhoids), with surgery, usually excisional hemorrhoidectomy, being reserved for more severe disease; for anal fissures, topical therapy using a calcium channel antagonist or nitroglycerine, followed by botulinum toxin and, less frequently, lateral internal sphincterotomy for chronic fissures. Anorectal biofeedback therapy is effective for managing DD and, together with bowel modifiers tailored to the specific symptoms (ie, constipation and/or diarrhea), is also used for FI. Biofeedback therapy is not widely accessible, and many patients are treated by pelvic floor physical therapists. For FI, minimally invasive options include sacral neuromodulation and anal dextranomer injection, with colostomy or anal sphincteroplasty now rarely required. Surgical interventions must balance long-term effectiveness with potential risks. Key topics for future research are proposed.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Bharucha AE, Knowles CH, Malcolm A, et al. An Evidence-Based Practical Review on Common Benign Anorectal Disorders: Hemorrhoids, Anal Fissure, Dyssynergic Defecation, and Fecal Incontinence. Gastroenterology. 2025. PMID: 41236452. doi:10.1053/j.gastro.2025.07.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。